Sojourner is trying to tell people that AVH is standing still. I don't think that 3 recruiting trials is standing still.
- Feasibility Study to Evaluate RECELL and Melanocyte Keratinocyte Transplantation Procedure for Repigmentation of Stable Vitiligo Lesions.
- RECELL® System Combined With Meshed Autograft for Reduction of Donor Skin Harvesting in Soft Tissue Reconstruction.
- RES® PreparedWith RECELL® Comparedto Standard of Care Dressings of Partial-thickness Burns in Ages 1-16 Year
Avita is also collaborating with others looking at the use of their product for rare skin conditions that have very poor prognosis and minimal options for treatment. They are also collaborating with the use of their cells for regenerative dermatology and chronic wounds.
RenovaCare are yet to start recruiting their first trial.
I know which company I would rather back.
Why AVH is a bargain right now / chart, page-107
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.51 |
Change
0.060(2.45%) |
Mkt cap ! $166.4M | |||
| Open | High | Low | Value | Volume |
| $2.48 | $2.52 | $2.46 | $323.3K | 129.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3222 | $2.48 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.51 | 524 | 1 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| AVH (ASX) Chart |